Home blood pressure monitoring with pharmacist support for older adults with multiple chronic conditions
Official title: Improving High Blood Pressure in Older Adults Living With Multiple Chronic Diseases - The SMBP Study
Run by University of Iowa · NCT06932029 · Data updated 2026-11-12
This study will test whether home blood pressure monitoring combined with clinical pharmacist support lowers systolic blood pressure in people 65 and older who have multiple chronic conditions and uncontrolled hypertension.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 65 Years and up |
| Sex | All |
| Enrollment | 930 (estimated) |
| Sponsor | University of Iowa Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 2 sites (Iowa City, Iowa and 1 other locations) |
| Status | Recruiting |
| Started | July 1, 2025 |
| Main results expected | April 2027 |
| Study ends | May 1, 2031 |
| Registry record updated | October 15, 2025 |
| Trial ID | NCT06932029 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 65 or older with documented, sustained elevated systolic blood pressure, multiple chronic conditions, the ability to consent and communicate in English or Spanish, and plans to receive care at a participating health system.
✕Probably not a fit
Patients in hospice, living in nursing or skilled care facilities, unable to consent or communicate in English/Spanish, actively receiving cancer chemotherapy or radiation, pregnant, or with already controlled blood pressure are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pragmatic, cluster-randomized trial compares self-measured blood pressure (SMBP) with conventional clinical support versus SMBP with clinical pharmacist support across primary care clinics. Clinics are randomized and eligible older adults (≥65) with sustained elevated systolic BP are enrolled and followed for 12 months, with the primary outcome being change in systolic blood pressure. The design uses broad inclusion criteria, EHR data collection, and minimal exclusions to maximize real-world generalizability. Secondary outcomes include self-reported treatment burden and planned subgroup analyses in rural and Black/African American older patients.
Why it matters
Potential benefit: If successful, this approach could help more older adults achieve lower systolic blood pressure and reduce their risk of stroke, heart attack, and kidney damage.
How similar studies have gone: Previous trials and quality-improvement programs have shown that SMBP and pharmacist-led medication management can improve blood pressure control, though this pragmatic trial focuses specifically on older adults with multiple chronic conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * The patient is at least 65 years of age * Patient is seen at least once in clinic or healthcare system in the previous 12 months * Patient has a six-month average (non-acute/maintenance) systolic blood pressure (SBP) \>= 145 mmHg, documented in the electronic medical record in last six months * Patient has a baseline in-clinic visit systolic blood pressure (SBP) \>= 140 mmHg * Patient plants to receive care from participating healthcare system for the next 24 months Exclusion Criteria: * The patient is enrolled in hospice or has an active referral to hospice care * The patient resides in a nursing home, in skilled nursing, rehabilitation facility, or memory care * The patient is not capable of providing informed consent * The patient is unable to communicate in English or Spanish * The patient is in active chemotherapy or radiation treatment for cancer * The patient is pregnant or has plans to become pregnant * The patient is currently participating in another study focused on blood pressure * The patient does not have a telephone
Where it's running
-
University of Iowa Health Care
Iowa City, Iowa, United States Recruiting -
University of Iowa
Iowa City, Iowa, United States Not yet recruiting
Study contacts
- Study coordinator: Korey Kennelty, PharmD, PhD
- Email: korey-kennelty@uiowa.edu
- Phone: 319-335-8862
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using low-dose aspirin after preeclampsia to improve recovery
This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.
-
IMB-guided health education to boost medication taking and blood pressure control in adults with hypertension
This study tests a health-literacy program based on Information-Motivation-Behavioral Skills to help adults with hypertension who don’t take their medicines regularly to take them more consistently and better control their blood pressure.
-
Renal Nerve Stimulation to Help Blood Pressure in AF and HFpEF
This study tests whether stimulating the kidneys with a catheter can safely lower blood pressure in adults with atrial fibrillation and HFpEF who also have hypertension.
-
Hypertension: Does Education Help Patients Manage Blood Pressure Better?
This study tests whether structured patient education improves blood pressure control and self-management in adults with hypertension who speak Turkish.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
Long-term GW906 treatment for people with essential hypertension
This trial tests whether long-term GW906 injections are safe and effective for adults with essential hypertension who completed an earlier GW906 study.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.